Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New telehealth program aims to ease the burden of advanced cancer for patients and families

NCT ID NCT06936878

First seen Dec 24, 2025 · Last updated Jun 23, 2026 · Updated 31 times

Summary

This study tests a program called BOLSTER, which offers six telehealth sessions with a nurse to help patients with advanced gynecologic or gastrointestinal cancers and their care partners build skills, manage symptoms, and cope with challenges. Participants also get access to a website with personalized educational materials. The goal is to see if the program improves quality of life and well-being for both patients and caregivers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dana-Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The University of Texas MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

BOLSTER Program (behavioral intervention: telehealth sessions and website)

What this could lead to

If it works, this program could provide a practical way to improve quality of life and coping skills for patients with advanced cancer and their caregivers.

What could go wrong

This is a behavioral support study, not a treatment for cancer itself. It may not reduce symptoms or improve well-being for everyone, and results depend on participant engagement.

Conditions

The condition(s) this trial relates to.

cancer digestive system cancer digestive system neoplasm female reproductive organ cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.